Auris Medical to provide update on intranasal betahistine program on Wednesday, October 17, 2018

World News: . []

Zug Switzerland October 12 2018 - Auris Medical Holding AG NASDAQ EARS a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health supportive care today announced that it...

More news and information about Auris Medical AG

Published By:

Globe Newswire: 12:30 GMT Friday 12th October 2018

Published: .

Search for other references to "auris" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us